00:54:20 EST Sun 26 Jan 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:TRIL from 2019-01-25 to 2020-01-24 - 36 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2020-01-23 08:40C:TRILTrillium Therapeutics Inc (2)5.56News ReleaseTrillium prices equity raise at $2.75 (U.S.) a share
2020-01-22 16:18C:TRILTrillium Therapeutics Inc (2)4.28News ReleaseTrillium arranges public offering of shares, preferreds
2020-01-16 09:14C:TRILTrillium Therapeutics Inc (2)3.67News ReleaseTrillium regains compliance with Nasdaq bid price rule
2020-01-07 09:43C:TRILTrillium Therapeutics Inc (2)1.51News ReleaseTrillium increases dosing for TTI-621 program
2019-11-14 08:19C:TRILTrillium Therapeutics Inc (2)0.375News ReleaseTrillium loses $29.77M in first nine months of 2019
2019-11-14 07:15C:TRILTrillium Therapeutics Inc (2)0.375SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-11-14 07:15C:TRILTrillium Therapeutics Inc (2)0.375SEDAR MD & ASEDAR MD & A
2019-10-22 09:23C:TRILTrillium Therapeutics Inc (2)0.365News ReleaseTrillium to discontinue discovery research activities
2019-10-22 09:06C:TRILTrillium Therapeutics Inc (2)0.365Resume TradingTrillium Therapeutics to resume at 6:50 a.m. PT
2019-10-22 08:56C:TRILTrillium Therapeutics Inc (2)0.365Halt TradingTrillium Therapeutics halted at 5:54 a.m. PT
2019-10-08 07:43C:TRILTrillium Therapeutics Inc (2)0.385News ReleaseTrillium given +180 days to comply with Nasdaq rules
2019-09-25 07:34C:TRILTrillium Therapeutics Inc (2)0.54News ReleaseTrillium appoints Skvarka as president, CEO
2019-09-05 09:03C:TRILTrillium Therapeutics Inc (2)0.38News ReleaseTrillium to present at investor conference Sept. 10
2019-08-13 09:37C:TRILTrillium Therapeutics Inc (2)0.405SEDAR MD & ASEDAR MD & A
2019-08-13 09:30C:TRILTrillium Therapeutics Inc (2)0.405SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-08-13 08:08C:TRILTrillium Therapeutics Inc (2)0.405News ReleaseTrillium loses $17.17-million in first half of 2019
2019-07-24 07:57C:TRILTrillium Therapeutics Inc (2)0.45News ReleaseTrillium to meet with FDA later this quarter
2019-07-02 09:00C:TRILTrillium Therapeutics Inc (2)0.44News ReleaseTrillium shareholders elect eight to board
2019-05-13 07:47C:TRILTrillium Therapeutics Inc (2)0.79News ReleaseTrillium Therapeutics spends $10.09M on R&D in Q1
2019-05-13 07:10C:TRILTrillium Therapeutics Inc (2)0.79SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-05-13 07:10C:TRILTrillium Therapeutics Inc (2)0.79SEDAR MD & ASEDAR MD & A
2019-04-30 07:57C:TRILTrillium Therapeutics Inc (2)0.89News ReleaseTrillium's president, CEO, director Stiernholm resigns
2019-04-15 08:22C:TRILTrillium Therapeutics Inc (2)0.92News ReleaseTrillium publishes TTI-621 paper re Sezary syndrome
2019-04-11 09:14C:TRILTrillium Therapeutics Inc (2)0.85News ReleaseTrillium warned of Nasdaq bid price requirement
2019-04-02 07:32C:TRILTrillium Therapeutics Inc (2)0.95News ReleaseTrillium begins STING agonist program
2019-03-27 17:11C:TRILTrillium Therapeutics Inc (2)0.97News ReleaseTrillium to present on Sting at meeting in Atlanta
2019-03-12 01:42C:TRILTrillium Therapeutics Inc (2)0.88News ReleaseTrillium spends $43.42-million on R&D in 2018
2019-03-11 17:15C:TRILTrillium Therapeutics Inc (2)0.88SEDAR Annual ReportSEDAR Annual Report
2019-03-11 17:15C:TRILTrillium Therapeutics Inc (2)0.88SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2019-03-11 17:15C:TRILTrillium Therapeutics Inc (2)0.88SEDAR MD & ASEDAR MD & A
2019-03-08 18:42C:TRILTrillium Therapeutics Inc (2)0.98News ReleaseTrillium closes public offering for $15-million (U.S.)
2019-02-26 21:19C:TRILTrillium Therapeutics Inc (2)Prospectus ApprovedTrillium Therapeutics to list additional shares Feb. 28
2019-02-22 09:11C:TRILTrillium Therapeutics Inc (2)0.97News ReleaseTrillium prices $15-million (U.S.) public sale
2019-02-22 09:05C:TRILTrillium Therapeutics Inc (2)1.65Resume TradingTrillium Therapeutics to resume at 6:30 a.m. PT
2019-02-22 09:00C:TRILTrillium Therapeutics Inc (2)1.65Halt TradingTrillium Therapeutics halted at 5:55 a.m. PT
2019-02-21 16:09C:TRILTrillium Therapeutics Inc (2)1.65News ReleaseTrillium Therapeutics arranges public offering